Trex Bio, Inc. engages in the manufacture of immunotherapies for autoimmune and inflammatory diseases. It focuses on studying the regulation of tissue inflammation to develop breakthrough medicines. The company was founded by Houman Ashrafian, Adil Daud, Wilson Liao, Diane Mathis, Drew Pardoll, Michael Rosenblum, Alison Simmons, and Jim Wells in May 24, 2018 and is headquartered in South San Francisco, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Trex Bio Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Trex Bio Inc. market cap is $371.07M.
What is the 52-week high for Trex Bio Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Trex Bio Inc. 52 week high is $16.56 as of October 30, 2026.
What is the 52-week low for Trex Bio Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Trex Bio Inc. 52 week low is $13.21 as of October 30, 2026.
What is Trex Bio Inc. stock price today?
Trex Bio Inc. stock price today is $13.32.
What was Trex Bio Inc. stock price yesterday?
Trex Bio Inc. stock price yesterday was $13.52.
What is the 50-day moving average of Trex Bio Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Trex Bio Inc. 50-day moving average is $14.17.